To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
May 31, 2007
H. Michael Shepard, PhD (Damon Runyon Fellow '78-'80) and Robert A. Weinberg, PhD (Scholar Award Review Panel Member and Damon Runyon Fellowship Sponsor) were awarded the 19th annual Warren Alpert Foundation Prize at Harvard Medical School, in recognition of their contribution to the development of the breast cancer therapy Herceptin, the first target-directed cancer treatment for solid tumors.